Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
14. October 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9108
Articles 1 - 20 / 182155
Omission of lateral isocenter shifts in robust optimization of proton therapy treatment plans for prostate cancer.
J Appl Clin Med Phys
O'Grady FT, Castro J, Kim DW, Fan J, Wang P.
PMID: 42870582 [PubMed - indexed for MEDLINE]
Prostate Cancer Therapy via Inhibition of Negative Immune Regulation.
Biomed Res Int
Dutta S, Sengupta P, Chowdhury U, Maldonado Rosas I, Kalita JC, Selvam MKP, Roychoudhury S.
PMID: 42870457 [PubMed - indexed for MEDLINE]
Liquid biopsy in bladder cancer: towards precision oncology.
J Transl Med
Chen C, Yang Y, Chen Z, Li X, Zhu Y, Zhai Y, Zheng J, Dai X, Zhou JG, Ma H, Ye X.
PMID: 42870280 [PubMed - indexed for MEDLINE]
Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial.
Insights Imaging
Greidanus J, Bernabei C, Chupetvloska K, Agrotis G, Mertens LS, van Rhijn BWG, van der Poel HG, van der Heijden MS, Beets-Tan RGH, Pizzi AD, Boellaard TN, Trebeschi S.
PMID: 42870138 [PubMed]
Fracture risk and fracture risk factor assessment among men at prostate cancer diagnosis.
Prostate Cancer Prostatic Dis
Shulman MJ, Darbinian JA, Chandra M, Harzstark AL, Lo JC.
PMID: 42869964 [PubMed - as supplied by publisher]
Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Multi-institutional Prospective Cohort Study.
Eur Urol Focus
Tan YG, Dudinec J, Kamat AM, Lim BJH, Ghoreifi A, Yuen JSP, Chen K, Kanesvaran R, Chan J, Shah AM, Tay KJ, Abern MR.
PMID: 42869744 [PubMed - as supplied by publisher]
Response to "Calendar-time bias in a TriNetX study of GLP-1 receptor agonists, SGLT2 inhibitors and bladder cancer survival".
Urol Oncol
Kohler J, Rodler S.
PMID: 42869700 [PubMed - as supplied by publisher]
Transitioning from template-based groin dissection to dynamic sentinel node biopsy in penile cancer: Prospective validation of a standardization step.
Urol Oncol
Prakash G, Shaikh S, Arora A, Pal M, Misra A, Gujela A, Bakshi G, Rangarajan V, Agrawal A, Menon S.
PMID: 42869699 [PubMed - as supplied by publisher]
Initial complete local therapy without systemic therapy versus systemic-therapy-based management in selected patients with oligometastatic renal cell carcinoma: a matched comparative study.
Radiother Oncol
Kim HU, Lee HI, Park I, Kim JK, Kim YJ.
PMID: 42869248 [PubMed - as supplied by publisher]
Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Multicenter Retrospective Study.
J Natl Compr Canc Netw
Gopalakrishnan D, Fujiwara Y, Collier KA, Park JJ, Zaemes JP, Lam ET, Alaklabi S, Jaeger EB, Barata PC, Kauffman EC, Atkins MB, Alva A, Yang Y, George S.
PMID: 42869085 [PubMed - as supplied by publisher]
[Molecular-Based Diagnostics and Therapy of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)].
Aktuelle Urol
Kesch C, Hadaschik B, von Amsberg G.
PMID: 42869040 [PubMed - as supplied by publisher]
Adenoma laterality and risk of subsequent colorectal cancer: Secondary analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer trial.
Surgery
Frebault J, Troester A, Huo L, Rudser K, Hassan I, Shaukat A, Goffredo P.
PMID: 42868921 [PubMed - as supplied by publisher]
Real-World Tumor-Informed Circulating Tumor DNA Dynamics and Survival Associations in Advanced Urothelial Cancer Treated With First-Line Enfortumab Vedotin and Pembrolizumab.
JCO Precis Oncol
Nimgaonkar V, Arbuiso A, Vlachou E, Johnson BA, Smith A, Kates M, Patel S, Singla N, Russell S, Rourke K, Elias R, Matoso A, Baraban EG, Hahn NM, Hoffman-Censits J.
PMID: 42868336 [PubMed - indexed for MEDLINE]
Fracture and Vertebral Augmentation Utilization Following Androgen Deprivation Therapy in Men With Prostate Cancer: A Propensity Score-matched Cohort Study.
Global Spine J
Taka T, Cummings C, Meng S, Miner A, Dietrich G, Shin D, Trivedi T, Goodwin R, Richardson W, Danisa O.
PMID: 42868235 [PubMed - as supplied by publisher]
Lower Urinary Tract Complications After Radiotherapy for Prostate Cancer: An Organ-Based Clinical Framework.
Int Braz J Urol
Gomes CM, do Nascimento LAP, Ockrim J, Laferreira LS, Nobrega R, Pace K, Loufopoulos I, Greenwell T.
PMID: 42868174 [PubMed - indexed for MEDLINE]
Joint Associations of Abdominal Obesity, General Obesity, and Smoking with Bladder Cancer Risk Among Postmenopausal Women: A Nationwide Cohort Study.
Cancer Epidemiol Biomarkers Prev
Han M, Park JH, Hong JY, Han K, Shen JJ.
PMID: 42867947 [PubMed - as supplied by publisher]
Opioid-free versus opioid-based anesthesia for robot-assisted radical prostatectomy: a single-center randomized controlled trial.
J Robot Surg
Sk, , Cicio M, Kowal T, Kwinta A, Bugielska R, Szpunar W, Szpor J, Maciejewska K, , Lonc T, Drygalski T, Maciejewski P.
PMID: 42867736 [PubMed - indexed for MEDLINE]
Artificial Intelligence for Prostate Cancer Detection and Screening on MRI in Global Populations: The SCARLET-1 Study.
Radiology
Saha A, Bosma JS, Twilt JJ, Ng ABCD, Asif A, Magudia K, Larson PEZ, Xie Q, Zhang X, Minh CP, Gitau SN, Schoots IG, Boomsma MF, Cuocolo R, Papanikolaou N, Regge D, Patel HD, Yakar D, Elschot M, Veltman J, Turkbey B, Obuchowski NA, Fütterer JJ, Padhani AR, Mayor N, Ahmed HU, Jäderling F, Nordström T, Eklund M, Kasivisvanathan V, de Rooij M, Huisman H, PI-CAI, PI-CAI.
PMID: 42867371 [PubMed - indexed for MEDLINE]
Urinary Extracellular Vesicle-Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer.
Int J Urol
Hashimoto M, Tomiyama E, Inoki L, Miki K, Nakayama T, Fujimoto S, Toyoda S, Kikuchi T, Ukekawa R, Yamamoto Y, Minami T, Yoshimura K, Nonomura N, Fujita K.
PMID: 42866931 [PubMed - indexed for MEDLINE]
Complementary Diagnostic Value of ZEB1 and CK7 in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Appl Immunohistochem Mol Morphol
Filipovi, Soldatovi, , Dun, Jevti, Nikoli, Vukajlovi, Radojevi.
PMID: 42866914 [PubMed - as supplied by publisher]
Articles 1 - 20 / 182155
Page 1 of 9108
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy